ES2151254T3 - Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2. - Google Patents

Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2.

Info

Publication number
ES2151254T3
ES2151254T3 ES97915396T ES97915396T ES2151254T3 ES 2151254 T3 ES2151254 T3 ES 2151254T3 ES 97915396 T ES97915396 T ES 97915396T ES 97915396 T ES97915396 T ES 97915396T ES 2151254 T3 ES2151254 T3 ES 2151254T3
Authority
ES
Spain
Prior art keywords
group
cox
inhibitors
oxazolone derivatives
oxazolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97915396T
Other languages
English (en)
Inventor
Duran Carles Puig
Noguera Ferr N Pujol
Forner Dolors Fernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8294266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2151254(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Prodesfarma SA filed Critical Almirall Prodesfarma SA
Application granted granted Critical
Publication of ES2151254T3 publication Critical patent/ES2151254T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO DE 2 - (3H) - OXAZOLONA DE FORMULA (I), DONDE R 1 ES UN GRUPO ALQUILO O NR SUP,4 R 5 , DONDE R 4 Y R 5 , CADA UNO INDEPENDIENTEMENTE, SON HIDROGENO O UN GRUPO ALQUILO O BENCILO; R 2 ES UN GRUPO NAFTILO, TETRAHIDRONAFTILO, FENILO SIN SUSTITUIR O FENILO SUSTITUIDO POR ENTRE 1 Y 3 ATOMOS DE HALOGENO O POR GRUPOS ALQUILO, HIDROXILO, ALCOXI O TRIFLUOROMETILO; Y R 3 ES HIDROGENO O UN GRUPO ALQUILO.
ES97915396T 1996-03-21 1997-03-19 Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2. Expired - Lifetime ES2151254T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009600685A ES2125161B1 (es) 1996-03-21 1996-03-21 Nuevos derivados de 2-(3h)-oxazolona.

Publications (1)

Publication Number Publication Date
ES2151254T3 true ES2151254T3 (es) 2000-12-16

Family

ID=8294266

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009600685A Expired - Lifetime ES2125161B1 (es) 1996-03-21 1996-03-21 Nuevos derivados de 2-(3h)-oxazolona.
ES97915396T Expired - Lifetime ES2151254T3 (es) 1996-03-21 1997-03-19 Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES009600685A Expired - Lifetime ES2125161B1 (es) 1996-03-21 1996-03-21 Nuevos derivados de 2-(3h)-oxazolona.

Country Status (29)

Country Link
US (1) US6869968B1 (es)
EP (1) EP0888316B1 (es)
JP (1) JP3810091B2 (es)
KR (1) KR100496395B1 (es)
CN (1) CN1110488C (es)
AR (1) AR006340A1 (es)
AT (1) ATE197294T1 (es)
AU (1) AU713811B2 (es)
BR (1) BR9708141A (es)
CA (1) CA2249420A1 (es)
CO (1) CO4780046A1 (es)
CZ (1) CZ294963B6 (es)
DE (1) DE69703437T2 (es)
DK (1) DK0888316T3 (es)
ES (2) ES2125161B1 (es)
GR (1) GR3035096T3 (es)
ID (1) ID16778A (es)
IL (1) IL126206A (es)
NO (1) NO311761B1 (es)
NZ (1) NZ331901A (es)
PE (1) PE42898A1 (es)
PL (1) PL188722B1 (es)
PT (1) PT888316E (es)
RU (1) RU2194043C2 (es)
TW (1) TW426674B (es)
UA (1) UA52645C2 (es)
UY (1) UY24499A1 (es)
WO (1) WO1997034882A1 (es)
ZA (1) ZA972203B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
ES2131015B1 (es) * 1997-09-12 2000-03-01 Almirall Prodesfarma Sa Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
ES2154561B1 (es) * 1998-09-25 2001-12-01 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
ES2168895A1 (es) * 1999-03-26 2002-06-16 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
ATE283048T1 (de) 1999-12-08 2004-12-15 Pharmacia Corp Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
ES2215474B1 (es) 2002-12-24 2005-12-16 J. URIACH & CIA S.A. Nuevos derivados de fosforamida.
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
CN1309717C (zh) * 2003-06-03 2007-04-11 李小虎 4－芳基－5h－噻吩－2－酮衍生物、其制法和用途
RU2270673C1 (ru) * 2004-08-17 2006-02-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" (ГОУ ВПО СибГМУ) Способ реабилитации больных после операции на щитовидной железе
CA2676413A1 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
ZW19786A1 (en) * 1985-10-17 1988-05-18 Hoffmann La Roche Heterocyclic compounds
US4866182A (en) 1988-02-18 1989-09-12 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoyl and aroyl oxazolones
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
DE4435547A1 (de) 1994-10-05 1996-04-11 Bayer Ag Sulfonylaminocarbonyltriazolinone mit über Sauerstoff und Schwefel gebundenen Substituenten
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique

Also Published As

Publication number Publication date
IL126206A (en) 2001-06-14
ES2125161A1 (es) 1999-02-16
PE42898A1 (es) 1998-08-12
MX9701944A (es) 1998-06-30
NZ331901A (en) 1999-10-28
AR006340A1 (es) 1999-08-25
CN1218459A (zh) 1999-06-02
UY24499A1 (es) 1997-04-02
DE69703437T2 (de) 2001-03-08
CO4780046A1 (es) 1999-05-26
NO984325D0 (no) 1998-09-17
ES2125161B1 (es) 1999-11-16
PL328915A1 (en) 1999-03-01
JP3810091B2 (ja) 2006-08-16
NO311761B1 (no) 2002-01-21
ATE197294T1 (de) 2000-11-15
AU2289397A (en) 1997-10-10
JP2000506876A (ja) 2000-06-06
NO984325L (no) 1998-11-23
DE69703437D1 (de) 2000-12-07
TW426674B (en) 2001-03-21
CA2249420A1 (en) 1997-09-25
CN1110488C (zh) 2003-06-04
PL188722B1 (pl) 2005-04-29
AU713811B2 (en) 1999-12-09
UA52645C2 (uk) 2003-01-15
HK1015371A1 (en) 1999-10-15
WO1997034882A1 (en) 1997-09-25
KR100496395B1 (ko) 2005-09-27
EP0888316A1 (en) 1999-01-07
ID16778A (id) 1997-11-13
GR3035096T3 (en) 2001-03-30
KR20000064727A (ko) 2000-11-06
IL126206A0 (en) 1999-05-09
BR9708141A (pt) 1999-07-27
ZA972203B (en) 1997-09-25
CZ294963B6 (cs) 2005-04-13
DK0888316T3 (da) 2000-11-27
EP0888316B1 (en) 2000-11-02
US6869968B1 (en) 2005-03-22
CZ297998A3 (cs) 1999-02-17
PT888316E (pt) 2001-02-28
RU2194043C2 (ru) 2002-12-10

Similar Documents

Publication Publication Date Title
ES2151254T3 (es) Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2.
AR240909A2 (es) Derivados de 2-(2'-alquilbenzoil) -1,3-ciclohexanodiona, composicion que los comprende y procedimiento para prepararlo"
NO902954D0 (no) Fremgangsmaate for fremstilling av substituerte kinazolinoner som angitensin ii-antagonister.
ES2155995T3 (es) Compuestos de 4-fenilpiperidina.
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
FI902555A0 (fi) Diarylstyrylkinolindisyror.
NO871861D0 (no) Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer.
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
AU7748687A (en) Phenolic corrosion inhibitors for coating materials
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
KR860005794A (ko) 이미다졸 유도체의 제조방법
ES2037708T3 (es) Un procedimiento para preparar un derivado de bencimidazol.
ES8205800A1 (es) Un procedimiento para la produccion de derivados de 1,2,3,4,5,6-hexahidro-6-fenil-azepino (4,5,b) indol.
AR246162A1 (es) Composicion antimicrobiana
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
AR017097A1 (es) Compuestos de 2-(3h)-oxazolona, utiles como inhibidores selectivos de cox-2; procedimiento para preparar dichos compuestos y composiciones farmaceuticasformuladas con dichos compuestos
DK184085A (da) Heterocycliske aminoforbindelser
DK248788D0 (da) Bicycliske sulfonamidderivater samt fremgangsmaade til fremstilling deraf
MX9700080A (es) Derivados de aril y heteroaril alcoxinaftaleno.
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
ES2001809A6 (es) Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas
ES2065992T3 (es) Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios.
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
AR006139A1 (es) Glutarimida, procedimientos para su preparación y su utilización.
ES8507490A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-propanol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 888316

Country of ref document: ES